Brief: Galderma Group To Present Eight Posters On Injectable Aesthetics At Amwc Dubai 2026
BRIEF-Galderma Group To Present Eight Posters On Injectable Aesthetics At Amwc Dubai 2026 Oct 21 (Reuters) - GALDERMA GROUP AG GALD.S:
TO PRESENT EIGHT POSTERS ON INJECTABLE AESTHETICS AT AMWC DUBAI 2026
TO PRESENT RESTYLANE DATA FROM FOUR STUDIES ON FACIAL INDICATIONS
SCULPTRA APPROVED FOR BODY USE IN UNITED ARAB EMIRATES
PHASE III DATA SHOWS RELFYDESS IMPROVES FROWN LINES AND CROW’S FEET FOR ALL PATIENTS
Source text: ID:nBw1z3pjka
Further company coverage: GALD.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Galderma AG
See all newsSwitzerland's Galderma nine-month sales rise on higher volumes, lifts outlook
Brief: Galderma Reports 9M Net Sales Of $4.765 Bln
Swiss stocks - Factors to watch on October 22
Focus: Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market
Brief: Galderma Group To Present Eight Posters On Injectable Aesthetics At Amwc Dubai 2026